DUBLIN, Dec. 28, 2023 /PRNewswire/ — The “In Vitro Diagnostics (IVD) Analyzers: Global Market” report has been added to ResearchAndMarkets.com’s offering.
The global market for IVD analyzers was valued at $12.2 billion in 2022, and is projected to reach $16.3 billion by the end of 2028 at a CAGR of 4.7 % during the forecast period of 2023 to 2028. The increasing elderly population, growing incidence of chronic diseases, widening use of diagnostics for prevention and monitoring, and growing adoption of PoC testing are driving market growth.
Based on analyzer type, the market is categorized into immunoassay analyzers, clinical chemistry analyzers, hematology and hemostasis analyzers, molecular diagnostic analyzers and PoC analyzers. The molecular analyzers segment, which held the third largest market share in 2022, is expected to show the highest CAGR, at 6.0%, during the forecast period. This segment’s share is attributed to the growing incidence of cancer and cancer-related diseases.
The market is also segmented into semi-automated and fully automated analyzers. The semi-automated segment accounted for 67.2% of the market in 2022. The fully automated segment is expected to grow at a higher CAGR of 6.4% during the forecast period, due to an increasing focus on automated and modulator laboratories. Its market share is expected to increase to 35.5% in 2028, up from 32.8% in 2022.
Based ontherapeutic area, the market for IVD analyzers is segmented into infectious diseases, diabetes, cardiology, oncology, nephrology and others. Infectious diseases accounted for 46.25 of the market in 2022 and this segment is expected to grow at a CAGR of 4.3% during the forecast period. The diabetes segment is a distant second, with 9.7% of the market in 2022, and it is expected to grow at a CAGR of 5.8% during the forecast period.
In this report, the end users of IVD analyzers consist of diagnostic laboratories, hospitals and clinics, research institutions, and others. Diagnostic labs accounted for 52.3% of the market share in 2022, and the segment is expected to grow at a CAGR of 5.0% during the forecast period. The increasing number of large laboratory networks with advanced instruments is driving the growth of this segment.
The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market.
The Report Includes
- 39 data tables and 34 additional tables
- An analysis of the global market for in vitro diagnostics (IVD) analyzers
- Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
- Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19’s impact on the IVD industry
- Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies’ ESG scores, future of ESG, case studies and the ESG practices of leading companies
- Overview of the emerging new technologies and patents in the market
- Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
- Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Market Breakdown by Analyzer Type
- Global Market for IVD Analyzers
- Market Analysis
- Immunoassay Analyzers
- Market Size and Forecast
- Clinical Chemistry Analyzers
- Hematology and Hemostasis Analyzers
- Molecular Diagnostic Analyzers
- Point-of-Care Analyzers
- Other Analyzers
Chapter 6 Market Breakdown by Level of Automation
- Semi-Automated Analyzers
- Fully Automated Analyzers
Chapter 7 Market Breakdown by Therapeutic Area
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
Chapter 8 Market Breakdown by End User
- Diagnostic Labs
- Hospitals and Clinics
- Research Institutions
- Other Users
Chapter 9 Market Breakdown by Region
Chapter 10 ESG Development
- Sustainability in the IVD Analyzer Industry: An ESG Perspective
- Key ESG Issues
- Environmental Performance of IVD Companies
- Social Performance of Key IVD Analyzers Companies
- Governance Performance of IVD Analyzer Companies
- Consumer Attitudes toward ESG in the IVD Analyzer Market
- Case Study
- Concluding Remarks
Chapter 11 Emerging Technologies and Developments
- Technologies in the Market
- Integration of AI and Machine Learning
- Digital Morphology
- Connected PoC Devices
- Microfluidics and Miniaturization
Chapter 12 Regulatory Scenario
Chapter 13 M&A Analysis
Chapter 14 Competitive Landscape
Chapter 15 Company Profiles
- Abbott Diagnostics
- Becton, Dickinson And Co.
- Biomerieux
- Bio-Rad Laboratories
- Danaher
- Ekf Diagnostics Holdings
- F. Hoffmann-La Roche
- Quidelortho
- Shenzhen Mindray Bio-Medical Electronics
- Siemens Healthineers
- Sysmex Corp.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/7d782w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo:https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/in-vitro-diagnostics-analyzers-global-market-analysis—-a-16-3-billion-market-by-2028–growing-at-a-cagr-of-4-7–302023195.html
SOURCE Research and Markets
Featured image: Megapixl © Ipopba